Fundraising Fox

Kronos Bio

New York, US · Founded 2017 · Delaware corporation · 4 known investors

kronosbio.com
Biotech

Founders & leadership

RB
Rebecka Belldegrun, M.D.Director
OS
Otello Stampacchia, Ph.D.Director
DM
David M. TanenExecutive Officer, Director, Promoter
JC
John C. Martin, Ph.D.Director
NB
Norbert Bischofberger, Ph.D.Executive Officer, Director
AS
Arie S. Belldegrun, M.D.Director
CW
Christopher WilfongExecutive Officer
JA
Joshua A. KazamDirector

Investors · 4

Reported raises · per SEC filings

Form D private placements
$105MraisedJul 2019 · 50 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jacob LovenDirector
  • Rebecka Belldegrun, M.D.Director
  • Norbert Bischofberger, Ph.D.Executive Officer, Director
  • John C. Martin, Ph.D.Director
  • Philip GutryExecutive Officer
  • David M. TanenExecutive Officer, Director, Promoter
  • Sean AlgeoExecutive Officer
  • Joshua A. KazamDirector
  • Otello Stampacchia, Ph.D.Director
  • Arie S. Belldegrun, M.D.Director
Offering amount
$105M
Amount sold
$105M
Proceeds to insiders
$360K
First sale
Jul 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$18MraisedJun 2018 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rebecka Belldegrun, M.D.Director
  • Otello Stampacchia, Ph.D.Director
  • David M. TanenExecutive Officer, Director, Promoter
  • John C. Martin, Ph.D.Director
  • Norbert Bischofberger, Ph.D.Executive Officer, Director
  • Arie S. Belldegrun, M.D.Director
  • Christopher WilfongExecutive Officer
  • Joshua A. KazamDirector
Offering amount
$18M
Amount sold
$18M
Proceeds to insiders
$360K
First sale
May 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.